SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
CT ORDER

CT ORDER

Other
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4/A

Amendment to a previously filed 4

3,4,5
View HTML
ARS

An annual report to security holders

Annual Filings
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe